Trademark: 78146097
Word

Status
Dead
Status Code
606
Status Date
Sunday, May 28, 2006
Serial Number
78146097
Mark Type
2000
Filing Date
Monday, July 22, 2002
Published for Opposition
Tuesday, March 4, 2003
Abandoned Date
Sunday, May 28, 2006

Trademark Owner History
Genetix Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 packaging cell line that produces retroviral gene therapy vectors for the treatment of cancer, AIDS, metabolic diseases, neurogenerative diseases, cardiovascular diseases, hemoglobinopathies and hormone deficiencies; packaging cell lines for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, hemoglobinopathies and hormone deficiencies; pharmaceutical preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases and hormone deficiencies
The mark consists of a stylized viral particle.

Trademark Events
Aug 2, 2006
Abandonment Notice Mailed - No Use Statement Filed
Aug 2, 2006
Abandonment - No Use Statement Filed
Feb 10, 2006
Assigned To Examiner
Aug 19, 2005
Extension 5 Granted
Aug 19, 2005
Extension 5 Filed
Aug 19, 2005
Teas Extension Received
Apr 6, 2005
Extension 4 Granted
Apr 6, 2005
Extension 4 Filed
Apr 6, 2005
Teas Extension Received
Nov 15, 2004
Extension 3 Granted
Nov 4, 2004
Extension 3 Filed
Nov 4, 2004
Teas Extension Received
Jun 2, 2004
Extension 2 Granted
May 25, 2004
Extension 2 Filed
May 28, 2004
Case File In Ticrs
May 25, 2004
Teas Extension Received
Nov 17, 2003
Extension 1 Granted
Nov 3, 2003
Extension 1 Filed
Nov 3, 2003
Teas Extension Received
May 27, 2003
Noa Mailed - Sou Required From Applicant
Mar 4, 2003
Published For Opposition
Feb 12, 2003
Notice Of Publication
Dec 12, 2002
Approved For Pub - Principal Register
Dec 10, 2002
Examiner's Amendment Mailed
Nov 26, 2002
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24